{"mainPropery":{"diseaseId":9941,"diseaseName":"Facioscapulohumeral muscular dystrophy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9941/facioscapulohumeral-muscular-dystrophy","synonyms":["FSHD","Muscular dystrophy, facioscapulohumeral","Facioscapulohumeral muscular dystrophy 1A","FSHMD1A","Muscular dystrophy, facioscapulohumeral, type 1a","FSHD1A","Landouzy-Dejerine muscular dystrophy"],"synonyms-with-source":[{"name":"FSHD"},{"name":"Muscular dystrophy, facioscapulohumeral"},{"name":"Facioscapulohumeral muscular dystrophy 1A"},{"name":"FSHMD1A"},{"name":"Muscular dystrophy, facioscapulohumeral, type 1a"},{"name":"FSHD1A"},{"name":"Landouzy-Dejerine muscular dystrophy"}],"identifiers":[{"identifierType":"OMIM","identifierId":"158900"},{"identifierType":"ORPHANET","identifierId":"269"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":882,"resourceName":"FSH Society, Inc.","address1":"450 Bedford Street","address2":"","address3":"","address4":"","address5":"","city":"Lexington","state":"MA","zip":"02420","country":"United States","phone":"617-669-1706 ","tty":"","tollFree":"","fax":"","email":"info@fshsociety.org","url":"http://www.fshsociety.org"},{"resourceID":935,"resourceName":"Muscular Dystrophy Association","abbreviation":"MDA","address1":"222 S Riverside Plaza","address2":"Suite 1500","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60606","country":"United States","phone":"","tty":"","tollFree":"1-833-275-6321 (Helpline)","fax":"","email":"resourcecenter@mdausa.org","url":"https://www.mda.org","freeText":""},{"resourceID":2281,"resourceName":"Friends of FSH Research","abbreviation":"","address1":"217 19th Place ","address2":"","address3":"","address4":"","address5":"","city":"Kirkland","state":"WA","zip":"98033","country":"","phone":"425-827-8954","tty":"","tollFree":"","fax":"","email":"connect@fshfriends.org","url":"http://www.fshfriends.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/158900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=158900' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Facioscapulohumeral muscular dystrophy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Facioscapulohumeral+muscular+dystrophy+1A%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Facioscapulohumeral muscular dystrophy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/facioscapulohumeral-muscular-dystrophy' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Facioscapulohumeral muscular dystrophy. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=269' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=fsh' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:158900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2340,"resourceId":3583,"resourceName":"Job Accommodation Network","descriptionText":"The <a href='https://askjan.org/disabilities/Muscular-Dystrophy.cfm' target='_blank'>Job Accommodation Network</a> (JAN) has information on workplace accommodations and disability employment issues related to this condition. JAN is a service of the Office of Disability Employment Policy in the U.S. Department of Labor.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Community Resources"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Facioscapulohumeral muscular dystrophy. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Facioscapulohumeral muscular dystrophy:<br />\r\n<a href='https://www.urmc.rochester.edu/neurology/national-registry.aspx' target='_blank'>National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":6798,"questionText":"What is facioscapulohumeral muscular dystrophy?","answerText":"<strong>Facioscapulohumeral muscular dystrophy</strong> is a disorder characterized by muscle weakness and wasting (atrophy). This condition gets its name from the areas of the body that are affected most often: muscles in the face (facio-), around the shoulder blades (scapulo-), and in the upper arms (humeral). The signs and symptoms of facioscapulohumeral muscular dystrophy usually appear in adolescence. However, the onset and severity of the condition varies widely. Facioscapulohumeral muscular dystrophy results from a deletion of genetic material from a region of DNA known as D4Z4. This region is located near one end of <a href=\"http://ghr.nlm.nih.gov/chromosome/4\" target=_blank>chromosome 4</a>.&nbsp;It&nbsp;is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> pattern.[5899] ","dateModified":"2013-03-15T11:14:00"},"basicQuestions":[],"references":[{"referenceId":7157,"authors":"Darras BT","articleTitle":"Facioscapulohumeral muscular dystrophy","bookWebsiteJournalTitle":"UpToDate","date":"2014","volume":"","pages":"","url":"http://www.uptodate.com/contents/facioscapulohumeral-muscular-dystrophy","dateAccessed":"2014-02-03T00:00:00","authors2":"Basow M","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}],"relatedDiseases":[{"relatedDiseaseId":7922,"relatedDiseaseName":"Muscular dystrophy","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":9135,"relatedDiseaseName":"Muscular Dystrophy - Late Onset","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":43524,"abbreviatedInquiry":"Is stem cell therapy being successfully used to treat people with facioscapulohumeral muscular dystrophy (FSHD)? Should people with FSHD exercise? If so, how often and how intensely?  Does drinking alcoholic beverages quicken the progression of FSHD? Is there a pharmaceutical drug to slow down the progression?","caseQuestions":[{"questionId":7276,"questionText":"Is stem cell therapy being used to treat people with facioscapulohumeral muscular dystrophy?","answerText":"The Food and Drug Administration has not approved stem cell therapy for the&nbsp;treatment of facioscapulohumeral muscular dystrophy. Clinical trials are&nbsp;investigating the use of this therapy for treatment of other forms of muscular dystrophy. Visit <a href=\"http://clinicaltrials.gov/ct2/results?term=&amp;recr=&amp;rslt=&amp;type=&amp;cond=dystrophy&amp;intr=stem+cell&amp;titles=&amp;outc=&amp;spons=&amp;lead=&amp;id=&amp;state1=&amp;cntry1=&amp;state2=&amp;cntry2=&amp;state3=&amp;cntry3=&amp;locn=&amp;gndr=&amp;rcv_s=&amp;rcv_e=&amp;lup_s=&amp;lup_e=\" target=\"_blank\">clinicaltrials.gov</a> to view these trials. In the United States private companies have infused patients with a variety of conditions with stem cells. FDA cautions consumers to make sure that any stem cell treatment they are considering has been approved by FDA or is being studied under a clinical investigation that has been submitted to and allowed to proceed by FDA. <a href=\"http://www.fda.gov/forconsumers/consumerupdates/ucm286155.htm\" target=\"_blank\">Click here</a> to learn vist the FDA Web site and learn&nbsp;more about stem cell treatments in the United States.<br />\r\n<br />\r\nThe Muscular Dystrophy Association provides information regarding the state of stem cell therapies for treatment of muscular dystrophies on their Web site at the following link.<br />\r\n<a href=\"http://mda.org/quest/research-briefs-stem-cells\">http://mda.org/quest/research-briefs-stem-cells</a>","dateModified":"2014-02-04T14:01:00","references":[]},{"questionId":7277,"questionText":"Is exercise recommended for people with facioscapulohumeral muscular dystrophy?","answerText":"Yes. Exercise is generally recommended for people with facioscapulohumeral muscular dystrophy (FSHD).&nbsp; People with FSHD may benefit from&nbsp;aerobic exercise at least three times a week for 30 minutes at an intensity to reach their age-adjusted target heart rate. Visit the <a href=\"http://www.heart.org/HEARTORG/GettingHealthy/PhysicalActivity/Target-Heart-Rates_UCM_434341_Article.jsp\" target=\"_blank\">American Heart Association</a> Web site to learn how to calculate your target heart rate.&nbsp;If aerobic exercise is not possible, people with FSHD may benefit from moderate intensity resistance training.[7157]","dateModified":"2014-02-03T14:36:00","references":[{"referenceId":7157,"authors":"Darras BT","articleTitle":"Facioscapulohumeral muscular dystrophy","bookWebsiteJournalTitle":"UpToDate","date":"2014","volume":"","pages":"","url":"http://www.uptodate.com/contents/facioscapulohumeral-muscular-dystrophy","dateAccessed":"2014-02-03T00:00:00","authors2":"Basow M","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":7278,"questionText":"Does alcohol consumption speed the progression of facioscapulohumeral muscular dystrophy?","answerText":"In our search we did not find information regarding alcohol consumption and facioscapulohumeral muscular dystrophy specifically.&nbsp;We recommend that you speak with your doctor before drinking alcohol. <br />\r\n<br />\r\nAccording to the Muscular Dystrophy Association,&nbsp;moderate amounts of&nbsp;alcohol isn't harmful to most people with neuromuscular disease in general.&nbsp;However the effects of alcohol may magnify&nbsp;exisiting problems with&nbsp;movement, coordination, sleep, swallowing, and breathing.&nbsp; Alcohol should be consumed in&nbsp;a safe situation with others around. Also, be sure to&nbsp;think about&nbsp;any other&nbsp;conditions or medications that you are on&nbsp;and the effect alcohol may have on these.[7158]<br />","dateModified":"2014-02-03T14:59:00","references":[{"referenceId":7158,"authors":"Medvescek C","articleTitle":"Easy-to-Eat Holiday Cheer","bookWebsiteJournalTitle":"Muscular Dystrophy Association: Quest Magazine","date":"2009","volume":"","pages":"","url":"http://quest.mda.org/article/easy-eat-holiday-cheer","dateAccessed":"2014-02-03T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7279,"questionText":"Are there medications to slow the progression of facioscapulohumeral muscular dystrophy?&nbsp;","answerText":"No. Currently there are no medications that have been shown to slow the progression of facioscapulohumeral muscular dystrophy (FSHD).","dateModified":"2014-02-03T15:03:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13575,"phenoTypeName":"EMG abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10993,"phenoTypeName":"Hyperlordosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9896,"phenoTypeName":"Mask-like facies","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5609,"phenoTypeName":"Abnormal eyelash morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14446,"phenoTypeName":"Abnormal retinal vascular morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11722,"phenoTypeName":"Palpebral edema","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11337,"phenoTypeName":"Sensorineural hearing impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14690,"phenoTypeName":"Abnormality of cardiovascular system morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3377,"phenoTypeName":"Abdominal wall muscle weakness","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":14728,"phenoTypeName":"Beevor's sign","percentRanges":"-"},{"phenoTypeId":3444,"phenoTypeName":"Calf muscle hypertrophy","percentRanges":"-"},{"phenoTypeId":15655,"phenoTypeName":"Childhood onset","percentRanges":"-"},{"phenoTypeId":5652,"phenoTypeName":"External ophthalmoplegia","percentRanges":"-"},{"phenoTypeId":6281,"phenoTypeName":"Exudative retinal detachment","percentRanges":"-"},{"phenoTypeId":2766,"phenoTypeName":"Facial palsy","percentRanges":"-"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","percentRanges":"-"},{"phenoTypeId":13724,"phenoTypeName":"Restrictive ventilatory defect","percentRanges":"-"},{"phenoTypeId":10588,"phenoTypeName":"Retinal telangiectasia","percentRanges":"-"},{"phenoTypeId":5270,"phenoTypeName":"Scapular winging","percentRanges":"-"},{"phenoTypeId":3439,"phenoTypeName":"Scapulohumeral muscular dystrophy","percentRanges":"-"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","percentRanges":"-"},{"phenoTypeId":5295,"phenoTypeName":"Shoulder girdle muscle atrophy","percentRanges":"-"},{"phenoTypeId":6231,"phenoTypeName":"Shoulder girdle muscle weakness","percentRanges":"-"},{"phenoTypeId":5256,"phenoTypeName":"Slow progression","percentRanges":"-"},{"phenoTypeId":15424,"phenoTypeName":"Tongue atrophy","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Facioscapulohumeral_muscular_dystrophy"}